Cytosorbents Crp
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $9,234 | $9,485 | $9,617 | $8,727 |
Gross Profit | 6,804 | 6,666 | 6,814 | 6,207 |
EBITDA | -3,692 | -2,926 | -3,210 | -3,518 |
EBIT | -4,051 | -3,615 | -3,887 | |
Net Income | -5,497 | -3,170 | 1,947 | -1,478 |
Net Change In Cash | 9,234 | 9,485 | 9,617 | 8,727 |
Free Cash Flow | -4,887 | -2,594 | -1,546 | -3,512 |
Cash | 6,249 | 7,536 | 10,204 | 11,587 |
Basic Shares | 62,804 | 62,753 | 67,166 | 60,732 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $37,063 | $35,594 | $31,084 | $34,688 |
Gross Profit | 26,491 | 25,125 | 21,953 | 20,733 |
EBITDA | -12,743 | -15,215 | -27,879 | -30,003 |
EBIT | -14,239 | -16,785 | -29,902 | -30,885 |
Net Income | -8,198 | -20,718 | -29,246 | -32,812 |
Net Change In Cash | 37,063 | 35,594 | 31,084 | 34,688 |
Cost of Revenue | -29,730 | |||
Free Cash Flow | -12,541 | -14,712 | -22,591 | -34,689 |
Cash | 6,249 | 3,279 | 14,131 | 22,144 |
Basic Shares | 62,231 | 54,434 | 44,656 | 43,573 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.09 |
2025-09-30 | -$0.04 |
2025-06-30 | $0.03 |
